Biotech

All Articles

BMS centers bispecific months after filing to work period 3 test

.Bristol Myers Squibb has possessed a whiplash change of mind on its own BCMA bispecific T-cell enga...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that looked after Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squ...

Asarina to close after initiatives to companion Tourette's drug neglect

.After connecting to more than 200 business to companion a Tourette syndrome treatment that showed t...

Novartis pens $150M upfront bispecifics take care of Dren Biography

.Novartis has had some bad luck with bispecific antitoxins in the past, but judging by the pharma's ...

AstraZeneca vegetations an EGFR plant along with Pinetree bargain worth $45M

.Pinetree Therapeutics will definitely aid AstraZeneca vegetation some trees in its pipeline with a ...

GRO collects $60M collection B to take gout arthritis therapy into center

.GRO Biosciences has actually ended the week with an additional $60.3 million in the banking company...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops chief executive officer

.Invite to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings and a...